Co-Authors
This is a "connection" page, showing publications co-authored by SARAH BLUTT and PEDRO PIEDRA.
Connection Strength
0.741
-
Single cell sequencing analysis of respiratory syncytial virus-infected pediatric and adult human nose organoids reveals age differences, proliferative diversity and identifies novel cellular tropism. J Infect. 2025 Oct; 91(4):106617.
Score: 0.238
-
Rotavirus antigenemia in children is associated with viremia. PLoS Med. 2007 Apr; 4(4):e121.
Score: 0.066
-
Streptococcus pneumoniae colonization modulates human nasal epithelial responses to respiratory syncytial virus infection. bioRxiv. 2026 Feb 05.
Score: 0.061
-
Strain-Specific Variability in Viral Kinetics, Cytokine Response, and Cellular Damage in Air-Liquid Cultures of Human Nasal Organoids After Infection with SARS-CoV-2. Viruses. 2025 Oct 06; 17(10).
Score: 0.060
-
Nasal microbionts differentially colonize and elicit cytokines in human nasal epithelial organoids. mSphere. 2025 Oct 29; 10(10):e0049325.
Score: 0.060
-
Nasal microbionts differentially colonize and elicit cytokines in human nasal epithelial organoids. bioRxiv. 2025 Apr 30.
Score: 0.058
-
Infant-derived human nasal organoids exhibit relatively increased susceptibility, epithelial responses, and cytotoxicity during RSV infection. J Infect. 2024 Dec; 89(6):106305.
Score: 0.056
-
Pediatric human nose organoids demonstrate greater susceptibility, epithelial responses, and cytotoxicity than adults during RSV infection. bioRxiv. 2024 Feb 01.
Score: 0.053
-
The human nose organoid respiratory virus model: an ex-vivo human challenge model to study RSV and SARS-CoV-2 pathogenesis and evaluate therapeutics. bioRxiv. 2021 Jul 28.
Score: 0.045
-
The Human Nose Organoid Respiratory Virus Model: an Ex Vivo Human Challenge Model To Study Respiratory Syncytial Virus (RSV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pathogenesis and Evaluate Therapeutics. mBio. 2021 02 22; 13(1):e0351121.
Score: 0.043